FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry and represents a pharmaceutical composition containing: {1S-[1α,2α,3β(1S*,2R*),5β]}-3-(7-{[2-(3;4-difluorophenyl)cyclopropyl]amino)-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol; an excipient representing mixed mannitol and dibasic calcium phosphate dihydrate; a binding agent representing hydroxypropyl cellulose; a disintegrant representing sodium starch glycolate; and one or more lubricating agents.
EFFECT: invention provides preparing the composition of the active compound possessing high stability and high bioavailability of the active agent.
12 cl, 1 ex
| Title |
Year |
Author |
Number |
| NOVEL CRYSTALLINE FORM OF TRIAZOLO(4,5-d)PYRIMIDINE |
2005 |
- Bolin Martin
- Kosgrouv Stiv
- Lassen Bo
|
RU2418802C2 |
| NEW CRYSTAL AND AMORPHOUS FORM OF TRYAZOL[4,5-d] PYRIMIDINE |
2001 |
- Bolin Martin
- Kosgrouv Stiv
- Lassen Bo
|
RU2325391C2 |
| TRIAZOLO[4,5-d]PYRIMIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF AND METHOD FOR TREATMENT, METHOD FOR THEIR PREPARING AND INTERMEDIATE COMPOUNDS |
1999 |
- Gil Sajmon
- Khardern Dehvid
- Ingoll Ehntoni
- Springtorp Brajan
- Uillis Pol
|
RU2317990C2 |
| NOVEL INTERMEDIATE COMPOUNDS FOR PRODUCING TRIAZOLO(4,5-d)PYRIMIDINE |
2012 |
- Gil Sajmon
- Khardern Devid
- Ingoll Entoni
- Springtorp Brajan
- Uillis Pol
|
RU2593201C2 |
| TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, METHODS FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION |
1998 |
- Gajl Simon
- Ingoll Ehntoni
- Springtorp Brajan
- Uillis Pol
|
RU2225407C2 |
| METHOD FOR OBTAINING [1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-DIFLUOROPHENYL)-CYCLOPROPYLAMINO]-5-(PROPYLTHIO)-3H-1,2,3-TRIAZOLO[4;5-d]PYRIMIDINE-3-YL]-5-(2-HYDROXYETHOXY)-CYCLOPENTANE-1,2-DIOL AND ITS INTERMEDIATE COMPOUNDS |
2009 |
- Aufdenblatten Roni
- Bokhlin Martin Khans
- Khellstrem Khelena
- Jokhansson Peter V.
- Larsson Ul'F G.
- Reknagel' Mikaehla
- Uehjss Andreas
|
RU2509082C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITOR OF HMG-REDUCTASE |
2000 |
- Krikmor Dzhozef Richard
- Uigginz Norman Al'Fred
|
RU2206324C1 |
| COMBINATIONS OF ALPHA-2-DELTA-LIGAND WITH SELECTIVE CYCLOIXYGENASE-2 INHIBITOR |
2003 |
- Tehjlor Charl'Z Prajs Ml.
|
RU2286151C2 |
| SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING INTEGRASE INHIBITOR |
2010 |
- Madzhur Madzhid
- Li Fen
- Ma Dechen
- Sottkhivirat Suttkhilug
|
RU2602865C2 |
| ORAL ANTITUMOUR DRUGS AND METHOD FOR ONCOLOGICAL DISEASES TREATMENT |
2016 |
- Shchekotikhin Andrej Egorovich
- Treshchalina Elena Mikhajlovna
- Treshchalin Ivan Dmitrievich
|
RU2639479C1 |
